Expression of JMJD2A in infiltrating duct carcinoma was markedly higher than fibroadenoma, and associated with expression of ARHI, p53 and ER in infiltrating duct carcinoma

Indian Journal of Experimental Biology

Volumn 51, Issue 3, 2013, Pages 208-217

  Li, Bei Xu ^a   Li, Jia ^a   Luo, Cheng Liang ^a   Zhang, Ming Chang ^a   Li, Hui ^a   Li, Li Liang ^a   Xu, Hong Fei ^a   Shen, Yi Wen ^a   Xue, Ai Min ^a   Zhao, Zi Qin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Correlation; Fibroadenoma; Infiltrating duct carcinoma; JMJD2A; Tumor related protein

Indexed keywords

DIRAS3 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HISTONE DEMETHYLASE; KDM4A PROTEIN, HUMAN; PROGESTERONE RECEPTOR; PROTEIN P53; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TP53 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; FEMALE; FIBROADENOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PAGET NIPPLE DISEASE; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; FEMALE; FIBROADENOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RHO GTP-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874774587     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E & Forman D, Global cancer statistics, CA Cancer J Clin, 61 (2011) 69.
2. Katoh M & Katoh M, Identification and characterization of JMJD2 family genes in silico, Int J Oncol, 24 (2004) 1623.
3. Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E & Dangond F, Functional characterization of JMJD2A, a histone deacetylase-and retinoblastoma-binding protein, J Biol Chem, 280 (2005) 28507.
4. Shin S & Janknecht R, Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D, Biochem Biophys Res Commun, 359 (2007) 742.
5. Trojer P & Reinberg D, Histone lysine demethylases and their impact on epigenetics, Cell, 125 (2006) 213.
6. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M & Shi Y, Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases, Cell, 125 (2006) 467.
7. Nottke A, Colaiácovo MP & Shi Y, Developmental roles of the histone lysine demethylases, Development, 136 (2009) 879.
8. Li BX, Zhang MC, Luo CL, Yang P, Li H, Xu HM, Xu HF, Shen YW, Xue AM & Zhao ZQ, Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro, J Exp Clin Cancer Res, 30 (2011) 90.
9. Li BX, Luo CL, Li H, Yang P, Zhang MC, Xu HM, Xu HF, Shen YW, Xue AM & Zhao ZQ, Effects of siRNA-mediated knockdown of jumonji domain containing 2A on proliferation, migration and invasion of the human breast cancer cell line MCF-7, Exp Ther Med, 4 (2012) 756.
10. Haupt LM, Thompson EW, Griffiths LR & Irving MG, IS-RT-PCR assay detection of MT-MMP in a human breast cancer cell line, Biochem Mol Biol Int, 39 (1996) 553.
11. Thompson EW, Paik S, Brünner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S & Lippman ME, Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines, J Cell Physiol, 150 (1992) 534.
12. Xu HF, Ding YJ, Shen YW, Xue AM, Xu HM, Luo CL, Li BX, Liu YL & Zhao ZQ, MicroRNA-1 represses Cx43 expression in viral myocarditis, Mol Cell Biochem, 362 (2012) 141.
13. Luo CL, Li BX, Li QQ, Chen XP, Sun YX, Bao HJ, Dai DK, Shen YW, Xu HF, Ni H, Wan L, Qin ZH, Tao LY & Zhao ZQ, Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice, Neuroscience, 184 (2011) 54.
14. Weber F, Aldred MA, Morrison CD, Plass C, Frilling A, Broelsch CE, Waite KA & Eng C, Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis, J Clin Endocrinol Metab, 90 (2005) 1149.
15. Zhou H, Huang HY, Shapiro E, Lepor H, Huang WC, Mohammadi M, Mohr I, Tang MS, Huang C & Wu XR, Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications intarget-based therapies, Carcinogenesis, 33 (2012) 770.
16. Cavaliere C, Corvigno S, Galgani M, Limite G, Nardone A & Veneziani BM, Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells, Cancer Sci, 101 (2010) 1661.
17. Du M, Yang X, Hartman JA, Cooke PS, Doerge DR, Ju YH & Helferich WG, Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice, Carcinogenesis, 33 (2012) 895.
18. Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N & Batra SK, MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells, Br J Cancer, 99 (2008) 520.
19. Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW & Okada H, Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development, PLoS One, 6 (2011) 7830.
20. Takaki T, Fukasawa K, Suzuki-Takahashi I & Hirai H, Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro, Biochem Biophys Res Commun, 316 (2004) 252.
21. Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC, Tsai SC, Seto E, Zhang Y, Kuzmichev A, Lane WS, Reinberg D, Harlow E & Branton PE, RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest, Mol Cell Biol, 21 (2001) 2918.
22. Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS & Yu Y, E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer, Oncogene, 25 (2006) 230.
23. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB & Bast RC Jr, NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas, Proc Natl Acad Sci USA, 96 (1999) 214.